Summary

This report is an essential source for in-depth information and data relating to India IIn vitro diagnostic dvices market. It also offers detailed and comprehensive coverage of market revenue, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the in vitro diagnostics market in India

Scope

-The report provides information on the Indian in vitro diagnostics market, broken down into detailed categories and segments such as In Vitro Diagnostics, Clinical Chemistry Test Reagents, Immunochemistry Test Reagents, Blood Test Reagents, Microbiology Test Reagents, Infectious Immunology, Test Reagents, Genetic Test Reagents, Self Testing, and Instruments.
-Total revenues, end users
-Market shares of all the key competitors.
-Key pipeline products that are set to shape the market, broken down by sector.
-Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis.
-Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
-Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
-Key mergers and acquisitions, partnerships, private equity investments and IPOs.
-Customer, hospitals and physicians data.

Reasons to buy

-Gain a strong understanding of the in vitro diagnostics devices market in India.
-Evaluate and compare the attractiveness of the market in the country.
-Identify growth segments and opportunities in each industry sector within the country.
-Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
-Analyze the competitiveness of the market in the country and identify hotspots.
-Develop strategies based on the latest product, brand, expansion and research and development news in the country.
-Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
-Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Table of Contents

1.1 List of Tables 7
1.2 List of Figures 10
2 Introduction 12
2.1 What Is This Report About? 12
3 Definitions of Markets Covered in This Report 13
3.1 In Vitro Diagnostics 13
3.2 Clinical Chemistry 13
3.3 Genetic Testing 14
3.4 Haematology 14
3.5 Histology And Cytology 16
3.6 Immuno Chemistry 17
3.7 Infectious Immunology 19
3.8 Microbiology Culture 19
4 Healthcare Sector Review 21
4.1 Healthcare Expenditure 21
4.2 Healthcare Infrastructure 24
4.3 Healthcare Policy 27
5 Regulation System 28
5.1 Medical Equipment Approval 28
5.2 Central Drugs Authority of India (CDAI) 29
5.3 Medical Device Regulatory Authority of India (MDRAI) 29
5.4 Classification of medical devices 29
6 Pricing and Reimbursement 31
6.1 Pricing and Reimbursement 31
7 Distribution Structure 32
7.1 Distribution Structure 32
8 In Vitro Diagnostics In India 33
8.1 In Vitro Diagnostics, India, Overall Revenue ($ mn), 2000-2015 33
8.2 In Vitro Diagnostics, India, Company Share (2007-2008) 39
9 Clinical Chemistry In India 40
9.1 Clinical Chemistry Overall Revenue (2000-2015) 40
9.2 Clinical Chemistry Distribution Share (2007-2008) 48
9.3 Clinical Chemistry, India, Company Share (2007-2008) 49
10 Genetic Testing In India 51
10.1 Genetic Testing Overall Revenue (2000-2015) 51
10.2 Genetic Testing Distribution Share (2007-2008) 53
10.3 Genetic Testing, India, Company Share (2007-2008) 54
11 Haematology In India 55
11.1 Haematology Overall Revenue (2000-2015) 55
11.2 Haematology Distribution Share (2007-2008) 71
11.3 Haematology, India, Company Share (2007-2008) 72
12 Histology and Cytology In India 73
12.1 Histology and Cytology Overall Revenue (2000-2015) 73
12.2 Histology And Cytology Distribution Share (2007-2008) 77
12.3 Histology And Cytology, India, Company Share (2007-2008) 78
13 Immuno Chemistry In India 79
13.1 Immuno Chemistry Overall Revenue (2000-2015) 79
13.2 Immuno Chemistry Distribution Share (2007-2008) 91
13.3 Immuno Chemistry, India, Company Share (2007-2008) 92
14 Infectious Immunology In India 94
14.1 Infectious Immunology Overall Revenue (2000-2015) 94
14.2 Infectious Immunology Distribution Share (2007-2008) 98
14.3 Infectious Immunology, India, Company Share (2007-2008) 99
15 Microbiology Culture In India 101
15.1 Microbiology Culture Overall Revenue (2000-2015) 101
15.2 Microbiology Culture Distribution Share (2007-2008) 107
15.3 Microbiology Culture, India, Company Share (2007-2008) 108
16 Overview of Key Companies in India In Vitro Diagnostics Market 110
16.1 Transasia Bio-Medicals Ltd. 110
16.2 F. Hoffmann-La Roche Ltd. 110
16.3 Siemens Healthcare 111
16.4 Sysmex Corporation 112
16.5 Abbott Laboratories 114
16.6 Beckman Coulter, Inc. 115
16.7 Ortho-Clinical Diagnostics Inc. 118
16.8 OLYMPUS CORPORATION 120
16.9 Qiagen N.V. 120
16.10 Span Diagnostics Ltd. 121
16.11 Trivitron Group of Companies 121
16.12 bioMerieux S.A. 122
16.13 Bio-Rad Laboratories, Inc. 122
16.14 Phadia AB 123
16.15 DiaSorin S.p.A 125
16.16 Becton, Dickinson and Company 126
16.17 Gen-Probe Incorporated 127
16.18 Inverness Medical Innovations, Inc. 130
16.19 Tulip Group 133
16.20 Mindray Medical International Limited 133
16.21 CL Micromed Pvt. Ltd. 133
16.22 Embee Diagnostics 134
16.23 Invitro Biotech Ltd. 134
16.24 Bhat Bio-tech India (P)Ltd 134
16.25 Accurex Biomedical Pvt. Ltd. 134
16.26 Jindal Medical & Scientific Instruments Company (Pvt.) Ltd. 135
16.27 ATNT Laboratories 135
16.28 Professional Biotech Pvt. Ltd. 135
17 Financial Deals Landscape 136
17.1 Acquisition 136
17.2 Partnerships 137
18 Recent Developments 140
18.1 Strategy And Business Planning 140
18.2 Government and Public Interest 141
19 Appendix 143
19.1  Research Methodology 143
19.2 Secondary Research 144
19.3 Primary Research 144
19.4 Models 145
19.5 Forecasts 145
19.6 Expert Panel Validation 145
19.7 Currency Conversion 146
19.8 Contact Us 147
19.9 Disclaimer 147

1.1 List of Tables
Table 1: Total Healthcare Expenditure, India, 2000 ¨C 2007 26
Table 2: Number of Doctors by Specialty in India, 2000-2006 29
Table 3: Wards by Specialty in India, 2000-2006 30
Table 4: In Vitro Diagnostics, India, Overall Revenue ($ mn), 2000-2015 37
Table 5: In Vitro Diagnostics, India, Cross-Category Analysis, 2000-2015 38
Table 6: In Vitro Diagnostics, India, Overall Revenue ($ mn), Historic, 2000-2008 40
Table 7: In Vitro Diagnostics, India, Overall Revenue ($ mn), Forecast, 2008-2015 42
Table 8: In Vitro Diagnostics, India, Company Share by Revenue ($ mn), 2007-2008 43
Table 9: Clinical Chemistry, India, Revenue ($ mn) by Segment, Historic, 2000-2008 45
Table 10: Clinical Chemistry, India, Revenue ($ mn) by Segment, Forecast, 2008-2015 47
Table 11: Clinical Chemistry Analyzers, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 48
Table 12: Clinical Chemistry Analyzers, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 49
Table 13: Urine Analysis, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 50
Table 14: Urine Analysis, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 51
Table 15: Clinical Chemistry, India, Distribution Share by Revenue ($mn), 2007-2008 52
Table 16: Clinical Chemistry, India, Company Share by Revenue ($ mn), 2007-2008 54
Table 17: Genetic Testing, India, Revenue ($ mn) by Segment, Historic, 2000-2008 55
Table 18: Genetic Testing, India, Revenue ($ mn) by Segment, Forecast, 2008-2015 56
Table 19: Genetic Testing, India, Distribution Share by Revenue ($mn), 2007-2008 57
Table 20: Genetic Testing, India, Company Share by Revenue ($ mn), 2007-2008 58
Table 21: Haematology, India, Revenue ($ mn) by Segment, Historic, 2000-2008 60
Table 22: Haematology, India, Revenue ($ mn) by Segment, Forecast, 2008-2015 62
Table 23: Haematology Reagents, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 63
Table 24: Haematology Reagents, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 64
Table 25: Immunohaematology, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 65
Table 26: Immunohaematology, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 66
Table 27: Haemostasis, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 68
Table 28: Haemostasis, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 70
Table 29: Haematology Rapid Tests, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 71
Table 30: Haematology Rapid Tests, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 72
Table 31: Haematology Cell Counters, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 73
Table 32: Haematology Cell Counters, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 74
Table 33: Haematology, India, Distribution Share by Revenue ($mn), 2007-2008 75
Table 34: Haematology, India, Company Share by Revenue ($ mn), 2007-2008 76
Table 35: Histology and Cytology, India, Revenue ($ mn) by Segment, Historic, 2000-2008 77
Table 36: Histology and Cytology, India, Revenue ($ mn) by Segment, Forecast, 2008-2015 78
Table 37: Histology, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 79
Table 38: Histology, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 80
Table 39: Histology And Cytology, India, Distribution Share by Revenue ($mn), 2007-2008 81
Table 40: Histology And Cytology, India, Company Share by Revenue ($ mn), 2007-2008 82
Table 41: Immuno Chemistry, India, Revenue ($ mn) by Segment, Historic, 2000-2008 84
Table 42: Immuno Chemistry, India, Revenue ($ mn) by Segment, Forecast, 2008-2015 86
Table 43: Disease Specific Immunochemistry, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 87
Table 44: Disease Specific Immunochemistry, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 88
Table 45: Drug Related Testing, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 89
Table 46: Drug Related Testing, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 90
Table 47: Endocrinology Tests, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 91
Table 48: Endocrinology Tests, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 92
Table 49: Immunochemistry Analyzers, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 93
Table 50: Immunochemistry Analyzers, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 94
Table 51: Immuno Chemistry, India, Distribution Share by Revenue ($mn), 2007-2008 95
Table 52: Immuno Chemistry, India, Company Share by Revenue ($ mn), 2007-2008 97
Table 53: Infectious Immunology, India, Revenue ($ mn) by Segment, Historic, 2000-2008 99
Table 54: Infectious Immunology, India, Revenue ($ mn) by Segment, Forecast, 2008-2015 101
Table 55: Infectious Immunology, India, Distribution Share by Revenue ($mn), 2007-2008 102
Table 56: Infectious Immunology, India, Company Share by Revenue ($ mn), 2007-2008 104
Table 57: Microbiology Culture, India, Revenue ($ mn) by Segment, Historic, 2000-2008 106
Table 58: Microbiology Culture, India, Revenue ($ mn) by Segment, Forecast, 2008-2015 108
Table 59: Microbiology Analyzers, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 109
Table 60: Microbiology Analyzers, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 110
Table 61: Microbiology Culture, India, Distribution Share by Revenue ($mn), 2007-2008 111
Table 62: Microbiology Culture, India, Company Share by Revenue ($ mn), 2007-2008 113
Table 63: Sysmex Corporation Pipeline Products by Equipment Type 116
Table 64: Sysmex Corporation Pipeline Products By Development Stage 116
Table 65: Sysmex Corporation Pipeline Products By Therapy Area 116
Table 66: Sysmex Corporation Pipeline Products By News Summary 117
Table 67: Abbott  Laboratories Pipeline Products by Equipment Type 118
Table 68: Abbott  Laboratories Pipeline Products By Development Stage 118
Table 69: Abbott  Laboratories Pipeline Products By Therapy Area 118
Table 70: Beckman Coulter, Inc. Pipeline Products by Equipment Type 119
Table 71: Beckman Coulter, Inc. Pipeline Products By Development Stage 120
Table 72: Beckman Coulter, Inc. Pipeline Products By Therapy Area 121
Table 73: Beckman Coulter, Inc. Pipeline Products By News Summary 121
Table 74: Ortho-Clinical Diagnostics Inc. Pipeline Products by Equipment Type 122
Table 75: Ortho-Clinical Diagnostics Inc. Pipeline Products By Development Stage 123
Table 76: Ortho-Clinical Diagnostics Inc. Pipeline Products By Therapy Area 123
Table 77: Phadia AB Pipeline Products by Equipment Type 127
Table 78: Phadia AB Pipeline Products By Development Stage 127
Table 79: Phadia AB Pipeline Products By Therapy Area 128
Table 80: Phadia AB Pipeline Products By News Summary 128
Table 81: DiaSorin S.p.A Pipeline Products by Equipment Type 129
Table 82: DiaSorin S.p.A Pipeline Products By Development Stage 129
Table 83: DiaSorin S.p.A Pipeline Products By Therapy Area 129
Table 84: Gen-Probe Incorporated Pipeline Products by Equipment Type 131
Table 85: Gen-Probe Incorporated Pipeline Products By Development Stage 132
Table 86: Gen-Probe Incorporated Pipeline Products By Therapy Area 132
Table 87: Gen-Probe Incorporated Pipeline Products By Clinical Trials 132
Table 88: Gen-Probe Incorporated Pipeline Products By News Summary 133
Table 89: Inverness Medical Innovations, Inc. Pipeline Products by Equipment Type 134
Table 90: Inverness Medical Innovations, Inc. Pipeline Products By Development Stage 135
Table 91: Inverness Medical Innovations, Inc. Pipeline Products By Therapy Area 135
Table 92: Inverness Medical Innovations, Inc. Pipeline Products By Clinical Trials 136
Table 93: Inverness Medical Innovations, Inc. Pipeline Products By News Summary 136
Table 94: PerkinElmer Acquires Surendra Genetic Labs 140
Table 95: Rosetta Genomics Enters Into Distribution Agreement With Super Religare Laboratories 141
Table 96: DxS Signs Cross-Licensing Agreement With  Epigenomics 142
Table 97: Prodesse Enters Into A licensing Agreement With Abbott Laboratories 143
Table 98:   USD to Local Currency, Average Exchange Rate 2008 150

1.2 List of Figures
Figure 1: Total Healthcare Expenditure in India, 2000-2007 26
Figure 2: Government and Private Healthcare Expenditure in India, 2007 27
Figure 3: Proposed Medical Equipment Classification in India, 2005 34
Figure 4: In Vitro Diagnostics, India, Overall Revenue ($ mn), 2000-2015 37
Figure 5:In Vitro Diagnostics, India, Cross-Category Analysis, 2000-2015 38
Figure 6: In Vitro Diagnostics, India, Overall Revenue ($ mn), Historic, 2000-2008 39
Figure 7: In Vitro Diagnostics, India, Overall Revenue ($ mn), Forecast, 2008-2015 41
Figure 8: In Vitro Diagnostics, India, Company Share (%), 2008 43
Figure 9: Clinical Chemistry, India, Revenue ($ mn) by Segment, Historic, 2000-2008 44
Figure 10: Clinical Chemistry, India, Revenue ($ mn) by Segment, Forecast, 2008-2015 46
Figure 11: Clinical Chemistry Analyzers, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 48
Figure 12: Clinical Chemistry Analyzers, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 49
Figure 13: Urine Analysis, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 50
Figure 14: Urine Analysis, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 51
Figure 15: Clinical Chemistry, India, Company Share (%), 2008 53
Figure 16: Genetic Testing, India, Revenue ($ mn) by Segment, Historic, 2000-2008 55
Figure 17: Genetic Testing, India, Revenue ($ mn) by Segment, Forecast, 2008-2015 56
Figure 18: Genetic Testing, India, Company Share (%), 2008 58
Figure 19: Haematology, India, Revenue ($ mn) by Segment, Historic, 2000-2008 59
Figure 20: Haematology, India, Revenue ($ mn) by Segment, Forecast, 2008-2015 61
Figure 21: Haematology Reagents, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 63
Figure 22: Haematology Reagents, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 64
Figure 23: Immunohaematology, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 65
Figure 24: Immunohaematology, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 66
Figure 25: Haemostasis, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 67
Figure 26: Haemostasis, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 69
Figure 27: Haematology Rapid Tests, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 71
Figure 28: Haematology Rapid Tests, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 72
Figure 29: Haematology Cell Counters, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 73
Figure 30: Haematology Cell Counters, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 74
Figure 31: Haematology, India, Company Share (%), 2008 76
Figure 32: Histology and Cytology, India, Revenue ($ mn) by Segment, Historic, 2000-2008 77
Figure 33: Histology and Cytology, India, Revenue ($ mn) by Segment, Forecast, 2008-2015 78
Figure 34: Histology, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 79
Figure 35: Histology, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 80
Figure 36: Histology And Cytology, India, Company Share (%), 2008 82
Figure 37: Immuno Chemistry, India, Revenue ($ mn) by Segment, Historic, 2000-2008 83
Figure 38: Immuno Chemistry, India, Revenue ($ mn) by Segment, Forecast, 2008-2015 85
Figure 39: Disease Specific Immunochemistry, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 87
Figure 40: Disease Specific Immunochemistry, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 88
Figure 41: Drug Related Testing, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 89
Figure 42: Drug Related Testing, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 90
Figure 43: Endocrinology Tests, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 91
Figure 44: Endocrinology Tests, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 92
Figure 45: Immunochemistry Analyzers, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 93
Figure 46: Immunochemistry Analyzers, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 94
Figure 47: Immuno Chemistry, India, Company Share (%), 2008 96
Figure 48: Infectious Immunology, India, Revenue ($ mn) by Segment, Historic, 2000-2008 98
Figure 49: Infectious Immunology, India, Revenue ($ mn) by Segment, Forecast, 2008-2015 100
Figure 50: Infectious Immunology, India, Company Share (%), 2008 103
Figure 51: Microbiology Culture, India, Revenue ($ mn) by Segment, Historic, 2000-2008 105
Figure 52: Microbiology Culture, India, Revenue ($ mn) by Segment, Forecast, 2008-2015 107
Figure 53: Microbiology Analyzers, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 109
Figure 54: Microbiology Analyzers, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 110
Figure 55: Microbiology Culture, India, Company Share (%), 2008 112
Figure 56:  Methodology 147